June 26, 2019
DayTwo, an Israeli company that analyzes gut microbiomes to assist with nutrition and glycemic control, has raised $31 million in Series B financing. Ofek Ventures and aMoon led the round, with additional support coming from prior backers Seventure Partners and Johnson & Johnson.
With this, the company brings its total backing to $48 million.
WHAT THEY DO
DayTwo’s platform asks patients to...
June 28, 2017
DayTwo, an Israeli startup focused on delivering insights to consumers based on their gut microbiome, has raised $12 million from an impressive suite of investors including Johnson & Johnson Innovation and the Mayo Clinic. Seventure Partners' Health for Life Capital Fund also contributed along with private investors including cofounder Marius Nacht.
The startup, which has raised $17 million...
November 2, 2016
San Francisco-based uBiome, which makes a direct-to-consumer microbial genomic testing kit, has closed on a $22 million Series B funding round, led by 8VC with additional funding from Slow Ventures, Stanford’s StartX Fund and various angel investors. The funding will be used to deploy uBiome’s new testing kit, SmartGut, a sequencing-based clinical microbiome screening test.
With an at-home...
September 26, 2016
Seattle-based Arivale, which offers a testing kit and companion app to create tailored wellness plans, is now available in California.
Billed as the “scientific path to wellness,” Arivale offers people a package that includes a Fitbit, collection containers for saliva, urine, cheek swabs, and a prescribed order of blood tests to do on their own time, plus a companion app. Users download the app...